ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Beclomethasone

Also written as “Beclomethasone dipropionate”, “Beclometasone/Formoterol/Glycopyrrolate” and “beclomethasone”.

Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Rhinitis, Allergic, Seasonal · Rhinitis, Allergic, Perennial · Graft vs Host Disease, led by 7 companies.

Drug pageBeclomethasone: every studyMany companies study it; this page follows only the 44 they lead. All 85 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Oct 28, 202044 company-led studies, 1 open or runningNext primary completion: Jun 2028 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Chiesi Farmaceutici220 open or runningphase 4since Oct 28, 2020Sep 29, 2006none ahead
Teva Pharmaceutical Industriesits history only140 open or runningphase 4since Oct 28, 2003Oct 28, 2003none ahead
Soligenixits history only30 open or runningphase 3since Jun 19, 2009Jun 19, 2009none ahead
Adamis Pharmaceuticalsits history only20 open or runningphase 3since Feb 6, 2019Feb 6, 2019none ahead
Enteron Pharmaceuticalsits history only10 open or runningphase 3since Oct 4, 2005Oct 4, 2005none ahead
Lunan Pharmaceutical Groupits history only11 open or runningphase 3since Jul 21, 2026Jul 21, 2026Jun 2028phase 3 · NCT07768891
SOFARits history only10 open or runningphase 1since Apr 26, 2021Apr 26, 2021none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Chiesi Farmaceutici only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 7 studies since Sep 29, 2006.

  1. Oct 11, 2011Phase 3 study in AsthmaNCT01475032 · 638 enrolled · Bulgaria, France, Germany and more
  2. Apr 23, 2012Phase 2 study in AsthmaNCT01584492 · 59 enrolled · Poland, Ukraine
  3. Aug 1, 20122 phase 3 studiesNCT01691677, NCT01658891
  4. Oct 4, 2012Phase 2 study in AsthmaNCT01803087 · 60 enrolled · Poland
  5. Aug 5, 2013Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT01917331 · 1,368 enrolled · Hungary
  6. Jan 9, 2014Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT02040597 · 42 enrolled · Poland
  7. Apr 11, 2014Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT02119234 · 36 enrolled · Poland
  8. May 21, 2014Phase 2 study in AsthmaNCT02148120 · 60 enrolled · United Kingdom
  9. Nov 15, 2016Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT02975843 · 28 enrolled
  10. Aug 23, 2017Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT03268226 · 20 enrolled · Belgium, Hungary
  11. Oct 28, 2020Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT04671355
  12. Apr 27, 2021Phase 3 study in AsthmaNCT04886999 · 78 enrolled · Italy
  13. May 3, 2021Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT04876677 · 25 enrolled · Belgium, Hungary
  14. Mar 4, 2022Phase 3 study in AsthmaNCT05292586 · 1,377 enrolled · United States

TargetBeta

NR3C1 →read by rule
“Glucocorticoid receptor agonist”ChEMBL 37, by rule

Other programs on NR3C1

ProgramCompanyFurthest phaseStudies
DexamethasoneruleAbbViephase 4174
BudesonideruleAstraZenecaphase 4167
fluticasone furoateruleGlaxoSmithKlinephase 497
PrednisoneruleJohnson & Johnsonphase 465
PrednisoloneruleSanofiphase 434
betamethasone dipropionateruleLEO Pharmaphase 427
MethylprednisolonerulePfizerphase 423
dexamethasone phosphateruleeyegate-pharmaceuticals-incphase 421
BetamethasoneruleLEO Pharmaphase 49
Triamcinoloneruleresearch-insight-llcphase 45
relacorilantruleCorcept Therapeuticsphase 322
Triamcinolone Acetonideruleclearside-biomedical-incphase 320

Studies

All 22 Chiesi Farmaceutici leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT05292586Asthma · United States3CompletedJun 24, 20241,377
NCT04876677Pulmonary Disease, Chronic Obstructive · Belgium, Hungary3CompletedJan 3, 202225
NCT04886999Asthma · Italy3CompletedFeb 1, 202378
NCT04671355Pulmonary Disease, Chronic Obstructive4WithdrawnDec 22, 20210
NCT03268226Pulmonary Disease, Chronic Obstructive · Belgium, Hungary3CompletedJan 30, 201920
NCT02975843Pulmonary Disease, Chronic Obstructive1CompletedMar 21, 201728
NCT02148120Asthma · United Kingdom2CompletedOct 201460
NCT02119234Pulmonary Disease, Chronic Obstructive · Poland1CompletedFeb 201536
NCT02040597Pulmonary Disease, Chronic Obstructive · Poland1CompletedApr 201542
NCT01917331Pulmonary Disease, Chronic Obstructive · Hungary3CompletedJan 14, 20161,368
NCT01803087Asthma · Poland2CompletedOct 201260
NCT01658891Asthma in Children · Denmark3WithdrawnNov 20150
NCT01691677Acute Rhinosinusitis · Italy3CompletedJan 2014166
NCT01584492Asthma · Poland, Ukraine2CompletedFeb 201359
NCT01475032Asthma · Bulgaria, France, Germany and more3CompletedSep 2012638
NCT00861926Asthma · Bulgaria, Croatia, Czechia and more3CompletedDec 7, 20101,714
NCT00497523Asthma · Poland, Ukraine3Completed283
NCT00497237Asthma · Bulgaria, Italy, Ukraine3CompletedMar 2010382
NCT00476268Asthma3CompletedJan 2005824
NCT00413387Asthma · Austria, Poland, Ukraine3CompletedAug 2005219
NCT00394368Asthma · Poland, Ukraine3Completed180
NCT00382889Asthma · Austria, Italy, Poland and more3Completed480

How it is read

Names in the registry

  • “Beclomethasone dipropionate”, 6 entries
  • “Beclometasone/Formoterol/Glycopyrrolate”, 2 entries
  • “beclomethasone”, 2 entries
  • “beclomethasone dipropionate plus formoterol fumarate combination”, 2 entries
  • “Beclometasone dipropionate/Formoterol Fumarate/Glycopyrronium”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.